• Health Care M&A Deals, June 4, 2021

    The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our HealthCareMandA.com Deal Database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. The largest deal of the week... Read More »
  • WELL Health Buys MyHealth Partners

    It’s been a busy year for WELL Health Technologies Corp. (TSX.V: WELL). In early February, the company announced the acquisition of CRH Medical Corporation (NYSE: CRHM), which provides physicians with innovative services and products for the treatment of gastrointestinal diseases, for $292.7 million. Following that, in March the company... Read More »
  • Convey Health Announces its Going Public

    Healthcare technology firm Convey Holding Parent, Inc. announced a plan to raise $200 million through its upcoming IPO. The offering will consist of 13.3 million shares at an expected price range between $14 and $16 per share. In 2020, the company generated $288 million in consolidated revenue, a 28% increase over the previous year. Convey... Read More »
  • National Health Investors Grabs Brookhaven Hospital

    The healthcare REIT National Health Investors, Inc. (NYSE: NHI) is adding a behavioral health hospital to its portfolio. NHI is buying Brookhaven Hospital, a 64-bed specialty behavioral health hospital in Tulsa, Oklahoma, that specializes in treating patients that have suffered a traumatic brain injury. The deal is valued at $42.3 million; $40.3... Read More »
  • One Medical Buys Iora Health

    The primary care clinic operator One Medical (NASDAQ: ONEM) has expanded its network size with the acquisition of Boston, Massachusetts-based Iora Health. Under the terms of the agreement, Iora Health shareholders will receive 56.1 million shares of One Medical stock valued at the company’s closing price of $35.59 on June 4, 2021, or... Read More »
Convey Health Announces its Going Public

Convey Health Announces its Going Public

Healthcare technology firm Convey Holding Parent, Inc. announced a plan to raise $200 million through its upcoming IPO. The offering will consist of 13.3 million shares at an expected price range between $14 and $16 per share. In 2020, the company generated $288 million in consolidated revenue, a 28% increase over the previous year. Convey Holding Parent, also known as Convey Health, provides specialized Medicare technology solutions and healthcare advisory services to their customers. Its clientele ranges from national health insurance plans to pharmacy benefit management firms. Convey currently operates out of Fort Lauderdale, Florida. Convey Health has been backed by private equity... Read More »
DarioHealth Corp. Buys wayForward

DarioHealth Corp. Buys wayForward

Telehealth demand is still strong. DarioHealth Corp. (NASDAQ: DRIO), a leading global digital therapeutics company that helps people with chronic conditions, announced last week it was buying PsyInnovations, Inc. (dba wayForward) for $25 million. wayForward shareholders will get an additional $5 million if revenues exceed a certain threshold in 2022.  wayForward is a behavioral health digital platform that includes AI-enabled screening to triage and navigate members to specific interventions, digital Cognitive Behavioral Therapy, self-directed care, expert coaching and access to in-person and telehealth provider visits. The company is currently providing its full suite of digital... Read More »

Science 37 Goes Public in SPAC Deal

Another week, another SPAC deal. This time, Science 37, Inc. is merging with LifeSci Acquisition II Corp. (NASDAQ: LSAQ), a special purpose acquisition company (SPAC) targeting the biopharma, medical technology, digital health and healthcare services sectors. The transaction values Science 37 at a total enterprise value of $1.05 billion and a fully distributed equity value of approximately $1.3 billion at signing. Science 37 shareholders could also get $125 million in achievement milestones.  Science 37 developed the Decentralized Clinical Trial Operating System, which provides workflow coordination, evidence generation and data synchronization, allowing companies to conduct fully... Read More »
DarioHealth Corp. Buys wayForward

Walmart Acquires Telehealth Platform

The retail behemoth Walmart (NYSE: WMT) is pushing deeper into healthcare. Last week, Walmart announced the acquisition of MeMD a national telehealth provider. The company was founded in 2010 and provides virtual care nationwide, leveraging the latest online technologies to deliver high-quality care 24/7. MeMD delivers medical and mental health visits to millions of members nationwide.  This is not Walmart’s first foray into healthcare. MeMD will be merged with Walmart Health, a network of primary care clinics providing services ranging from optometry and mental health counseling services to dental care. The first location opened in 2019 in Dallas, but by the end of 2021, the company... Read More »
Accolade Acquires Telehealth Platform PlushCare

Accolade Acquires Telehealth Platform PlushCare

Telehealth demand is still going strong. Accolade, Inc. (NASDAQ: ACCD), a Seattle-based digital health company, has announced the acquisition of PlushCare, a leading virtual primary care and mental health platform that offers virtual doctor visits to patients in all 50 U.S. states. The deal was valued at $390 million, consisting of $40 million in cash and $340 million in Accolade common stock. Additionally, Accolade will pay up to an additional $70 million payable upon the achievement of defined revenue milestones. In 2020, PlushCare generated $35 million in unaudited revenues.  In the news release, Accolade stated that it expects the acquisition will be accretive to its growth rate and... Read More »
Microsoft Pushes Deeper Into Health With Nuance Buy

Microsoft Pushes Deeper Into Health With Nuance Buy

The technology and software giant Microsoft Corp. (NASDAQ: MSFT) is making another big push into the healthcare market. The company is buying Nuance Communications, Inc. for $19.7 billion ($56.00 per share) in cash, the largest transaction in the healthcare market of the year so far. The price is a 23% premium to the closing price of Nuance on Friday, April 9, and is valued at approximately 14.25x and 89.47x Nuance’s Q4:20 annualized revenue and EBITDA, respectively. Nuance provides conversational AI and cloud-based ambient clinical intelligence for healthcare providers. Nuance’s products include the Dragon Ambient eXperience, Dragon Medical One and PowerScribe One for radiology... Read More »